Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TP9M
|
||||
Former ID |
DNCL002535
|
||||
Drug Name |
ACY-1215
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Acetylon Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H27N5O3
|
||||
InChI |
InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)
|
||||
InChIKey |
QGZYDVAGYRLSKP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
125005606, 138910892, 161005252, 162012001, 163370731, 163620996, 163686328, 164144445, 164193966, 174006356, 175451991, 176253792, 178103589, 186022497, 189253967, 198988199, 219813871, 223391680, 223637710, 223705206, 226880432, 249859092, 250220890, 251962941, 252071791, 252214662, 252445340, 252552933
|
||||
Target and Pathway | |||||
Target(s) | Histone deacetylase | Target Info | Modulator | [544487] | |
Histone deacetylase 6 | Target Info | Modulator | [544487] | ||
KEGG Pathway | Alcoholism | ||||
Viral carcinogenesis | |||||
Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
Signaling events mediated by HDAC Class I | |||||
References | |||||
Ref 524684 | ClinicalTrials.gov (NCT02091063) ACY-1215 for Relapsed/Refractory Lymphoid Malignancies. U.S. National Institutes of Health. | ||||
Ref 542040 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7010). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.